/
/
/
טיפול בתאים דנדריטיים שמקורם במונוציטים (mo-DCs) עם סיאלידאז
This content is Free Access.
277 Views
•
03:03 min
•
October 20, 2023
DOI:
1Associate Laboratory i4HB – Institute for Health and Bioeconomy, NOVA School of Science and Technology,Universidade NOVA de Lisboa, 2UCIBIO – Applied Molecular Biosciences Unit, Department of Life Sciences, NOVA School of Science and Technology,Universidade NOVA de Lisboa, 3LAQV and REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia,Universidade NOVA de Lisboa, 4Department of Microbiology and Immunology,Albert Einstein College of Medicine, 5Department of Oncology,Albert Einstein College of Medicine, 6Stemmatters, Biotecnologia e Medicina Regenerativa SA, Parque de Ciência e Tecnologia Avepark,Zona Industrial da Gandra, 7CDG & Allies – Professionals and Patient Associations International Network (CDG & Allies – PPAIN), Department of Life Sciences, NOVA School of Science and Technology,Universidade NOVA de Lisboa
Read Article
Cite this Article
Luz, V. C. C., Silva, Z., Sobral, P., Tanwar, A., Paterson, R. L., Videira, P. A. Treatment of the Monocyte-Derived Dendritic Cells (mo-DCs) with Sialidase. J. Vis. Exp. (Pending Publication), e200351, doi:10.3791/200351 (2023).
Copy